An Open-Label, Dose Confirmation and Dosimetry Study of Interstitial 131 I-chTNT-1/B MAb (COTARA(TM)) For the Treatment of Glioblastoma Multiforme (GBM) at 1st or 2nd Relapse
Phase of Trial: Phase I
Latest Information Update: 22 Feb 2016
At a glance
- Drugs Iodine I 131 derlotuximab biotin (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 11 Feb 2010 Long-term follow-up data reported in Current Cancer Therapy Reviews, as reported by Peregrine Pharmaceuticals.
- 19 Oct 2007 Status changed from in progress to completed.
- 13 Jun 2007 Status change from recruiting to in progress.